Why Xeris Biopharma Shares Are Trading Higher Today
Portfolio Pulse from Lekha Gupta
Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares are trading higher by around 9% after the company revised its FY23 outlook. The company raised the lower end of its revenue guidance and its cash, cash equivalents, and short-term investment outlook. It also announced the successful formulation of the XeriJect formulation of TEPEZZA, which could lead to further development milestones and royalties.
October 16, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xeris Biopharma's stock is trading higher after the company revised its FY23 outlook upwards. The successful formulation of the XeriJect formulation of TEPEZZA could lead to further development milestones and royalties.
The company's upward revision of its FY23 outlook and the successful formulation of the XeriJect formulation of TEPEZZA, which could lead to further development milestones and royalties, are positive news that could drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100